Medicine & Life Sciences
dupilumab
100%
Nasal Polyps
75%
Nose
47%
Biological Products
21%
Interleukin-4 Receptors
10%
Monoclonal Antibodies
10%
Therapeutics
9%
Western World
8%
Phase III Clinical Trials
8%
Smell
8%
Interleukin-13
8%
Interleukin-4
6%
Glucocorticoids
6%
Cost-Benefit Analysis
6%
Asthma
5%
Steroids
5%
Costs and Cost Analysis
4%
Inflammation
4%
Safety
4%
Recurrence
4%
Population
2%
Engineering & Materials Science
Disease control
87%
Glucocorticoids
57%
Atopic Dermatitis
56%
Cost effectiveness
30%
Costs
11%
Chemical Compounds
Nasal
77%
Glucocorticoid
10%
Agent Interacting With Transmitter, Hormone or Drug Receptor
9%
Safety
7%
Block Like Crystal
5%
Force
5%
Social Sciences
evidence
24%
costs
13%
Western world
12%
Clinical Trials
12%
paradigm
7%